SEP 9, 2026 · INTERVENTIONAL STUDY
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
ClinicalTrials.gov
This is a post-marketing registry study with no results yet reported; it is designed to collect safety and effectiveness data prospectively but carries no outcome data to assess.
Reported
Planned enrollment400
Primary outcome measure 1Confirmed Ipsilateral Breast Tumor Recurren…
Primary outcome measure 2Confirmed and suspected Ipsilateral Breast…